SCICLONE PHARMACEUTICALS (HLDGS) LT financial statements, including revenue, expenses, profit, and loss
The total revenue of 6600 for the last semiannual is 1.68 B HKD, and it's 7.52% lower compared to the previous semiannual. The net income of H2 23 is 531.22 M HKD.